Liza Vertinsky: News Releases and In the News
Vertinsky: For medical breakthroughs, change scientific collaboration
SCOTUS: Health law and regulatory power
In June, the U.S. Supreme Court decided California v. Texas, the fifth Affordable Care Act (ACA) case to reach the court since the Act’s passage in 2010. California v. Texas asserted that the Tax Cuts and Jobs Act of 2017 rendered the ACA unconstitutional by amending it. The Supreme Court rejected the case on standing grounds.
Vertinsky: FDA COVID-19 plasma decision may be political, rushed
Professor Liza Vertinsky joined two other law professors in an op-ed that criticizes the FDA's recent announcement that it would authorize emergency use of investigational convalescent plasma as a treatment for COVID-19. They question whether the decision reflected extreme political pressure and a departure from evidence-based standards.
In sprint for COVID-19 vaccine, research collaborators may run into IP problems
The rush to collaborate on vaccines and treatments for Covid-19 may lead researchers to overlook precautions they normally would take concerning ownership of intellectual property, Bloomberg Law reports. Associate Professor Liza Vertinsky agrees. "When you're doing things quickly in response to an emergency, all the problems you normally have in collaborations get worse."
Left to our own devices: Ownership in the digital age
In 2014, digital music downloads and streaming subscriptions overtook CD sales for the first time. The development raised a pointed question. Who owns what in the digital age?
Are patents getting in the way of innovation?
Executive, judicial and legislative branches are trying to untangle the web of technological innovation.
Emory Law conference addresses legal, ethical end-of-life issues
A March 5 conference at Emory Law will address what is often the most emotionally fraught and expensive periods of medical care: the end of life.